Ignite Creation Date:
2024-05-06 @ 7:36 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06078696
Status:
RECRUITING
Last Update Posted:
2023-10-12
First Post:
2023-08-30
Brief Title:
Siplizumab for Sickle Cell Disease Transplant
Sponsor:
Markus Mapara
Organization:
Columbia University
Organization Data
Organization:
Columbia University
Class:
OTHER
Study ID:
AAAU5053
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Markus Mapara
Lead Sponsor Class:
OTHER
Responsible Party:
Markus Mapara
Responsible Party Title:
Professor of Medicine Director Bone Marrow Transplantation and Cell Therapy Program
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Columbia University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ITB-Med LLC | INDUSTRY |